Behavioral Deficit and Decreased GABA Receptor Functional Regulation in the Hippocampus of Epileptic Rats: Effect of Bacopa monnieri

By Mathew Jobin   Gangadharan Gireesh   Kuruvilla Korah   Paulose C.  

Neurochemical Research, Vol. 36, Iss. 1, 2011-01 ,pp. : 7-16

Springer Publishing Company

Access to resources Recommend Favorite

Meta-analysis: the efficacy of nootropic agent Cerebrolysin in the treatment of Alzheimer’s disease

By Wei Z.-H.   He Q.-B.   Wang H.   Su B.-H.   Chen H.-Z.  

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 629-634

Springer Publishing Company

Access to resources Recommend Favorite

Controversies in Alzheimer's disease drug development

By Cummings Jeffrey  

International Review of Psychiatry, Vol. 20, Iss. 4, 2008-08 ,pp. : 389-395

Informa Healthcare

Access to resources Recommend Favorite

Neuroprotective Potential of Bacopa monnieri and Bacoside A Against Dopamine Receptor Dysfunction in the Cerebral Cortex of Neonatal Hypoglycaemic Rats

By Thomas Roshni   Joy Shilpa   Ajayan M.   Paulose C.  

Cellular and Molecular Neurobiology, Vol. 33, Iss. 8, 2013-11 ,pp. : 1065-1074

Springer Publishing Company

Access to resources Recommend Favorite

Drug discovery for Alzheimer’s disease: The end of the beginning

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 1-8

Humana Press, Inc

Access to resources Recommend Favorite